186 related articles for article (PubMed ID: 24754309)
1. Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.
Kaku Y; Nagaya H; Tsuchiya A; Kanno T; Gotoh A; Tanaka A; Shimizu T; Nakao S; Tabata C; Nakano T; Nishizaki T
Cancer Sci; 2014 Jul; 105(7):883-9. PubMed ID: 24754309
[TBL] [Abstract][Full Text] [Related]
2. 1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug.
Kanno T; Tanaka A; Shimizu T; Nakano T; Nishizaki T
Pharmacology; 2013; 91(5-6):339-45. PubMed ID: 23817168
[TBL] [Abstract][Full Text] [Related]
3. The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer.
Kaku Y; Tsuchiya A; Kanno T; Nakao S; Shimizu T; Tanaka A; Nishizaki T
Cancer Chemother Pharmacol; 2015 Mar; 75(3):527-35. PubMed ID: 25567349
[TBL] [Abstract][Full Text] [Related]
4. 1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1- yloxy)propan-2-ol may be a promising anticancer drug.
Nishizaki T; Kanno T; Tsuchiya A; Kaku Y; Shimizu T; Tanaka A
Molecules; 2014 Dec; 19(12):21462-72. PubMed ID: 25532843
[TBL] [Abstract][Full Text] [Related]
5. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
6. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
[TBL] [Abstract][Full Text] [Related]
8. Naftopidil is useful for the treatment of malignant pleural mesothelioma.
Mikami K; Nagaya H; Gotoh A; Kanno T; Tsuchiya A; Nakano T; Nishizaki T
Pharmacology; 2014; 94(3-4):163-9. PubMed ID: 25301502
[TBL] [Abstract][Full Text] [Related]
9. Diarachidonoylphosphoethanolamine induces necrosis/necroptosis of malignant pleural mesothelioma cells.
Kaku Y; Tsuchiya A; Kanno T; Nakano T; Nishizaki T
Cell Signal; 2015 Sep; 27(9):1713-9. PubMed ID: 26004138
[TBL] [Abstract][Full Text] [Related]
10. A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.
Nishikawa S; Tanaka A; Matsuda A; Oida K; Jang H; Jung K; Amagai Y; Ahn G; Okamoto N; Ishizaka S; Matsuda H
Cancer Med; 2014 Apr; 3(2):416-25. PubMed ID: 24510578
[TBL] [Abstract][Full Text] [Related]
11. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
Yamaji M; Ota A; Wahiduzzaman M; Karnan S; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Haniuda M
Cancer Med; 2017 Nov; 6(11):2646-2659. PubMed ID: 28960945
[TBL] [Abstract][Full Text] [Related]
12. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
13. TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages.
Yuan BZ; Chapman J; Ding M; Wang J; Jiang B; Rojanasakul Y; Reynolds SH
BMC Cancer; 2013 Mar; 13():140. PubMed ID: 23517112
[TBL] [Abstract][Full Text] [Related]
14. The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1.
Lee KA; Lee YJ; Ban JO; Lee YJ; Lee SH; Cho MK; Nam HS; Hong JT; Shim JH
Int J Mol Med; 2012 Jul; 30(1):21-7. PubMed ID: 22552784
[TBL] [Abstract][Full Text] [Related]
15. HUHS1015 Suppresses Colonic Cancer Growth by Inducing Necrosis and Apoptosis in Association with Mitochondrial Damage.
Kaku Y; Tsuchiya A; Shimizu T; Tanaka A; Nishizaki T
Anticancer Res; 2016 Jan; 36(1):39-48. PubMed ID: 26722026
[TBL] [Abstract][Full Text] [Related]
16. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
Lam SK; Li YY; Zheng CY; Ho JC
Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
[TBL] [Abstract][Full Text] [Related]
18. Licochalcone A induces apoptosis in malignant pleural mesothelioma through downregulation of Sp1 and subsequent activation of mitochondria-related apoptotic pathway.
Kim KH; Yoon G; Cho JJ; Cho JH; Cho YS; Chae JI; Shim JH
Int J Oncol; 2015 Mar; 46(3):1385-92. PubMed ID: 25586190
[TBL] [Abstract][Full Text] [Related]
19. [Effects of microRNA-106b on migration and invasion of human malignant pleural mesothelioma cell NCI-H2452].
Gao YN; Zhang M; Zhang FF; Jia ZY; Yuan XY; Zhu LJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):648-654. PubMed ID: 37805422
[No Abstract] [Full Text] [Related]
20. AMP converted from intracellularly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis.
Nogi Y; Kanno T; Nakano T; Fujita Y; Tabata C; Fukuoka K; Gotoh A; Nishizaki T
Cell Physiol Biochem; 2012; 30(1):61-74. PubMed ID: 22759956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]